BBA
ACGN

Baker Bros. Advisors’s Aceragen Inc ACGN Stock Holding History

Baker Bros. Advisors’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-120,543
Closed -$2.66M – 130
2021
Q1 		$2.66M Sell
120,543
-150,833
-56% -$11.3M 0.01% 110
2020
Q4 		$16.9M Hold
271,376
– – 0.06% 60
2020
Q3 		$9.86M Hold
271,376
– – 0.04% 67
2020
Q2 		$8.25M Hold
271,376
– – 0.04% 68
2020
Q1 		$6.08M Hold
271,376
– – 0.04% 60
2019
Q4 		$8.39M Hold
271,376
– – 0.04% 55
2019
Q3 		$13.3M Buy
271,376
+174
+0.1% +$7.64K 0.09% 48
2019
Q2 		$12.3M Sell
271,202
-13,782
-5% -$652K 0.08% 46
2019
Q1 		$12.3M Buy
284,984
+215
+0.1% +$10.4K 0.08% 45
2018
Q4 		$13.4M Buy
284,769
+138
+0% +$15.9K 0.11% 44
2018
Q3 		$43.1M Buy
284,631
+249,067
+700% +$109M 0.28% 29
2018
Q2 		$51M Buy
35,564
+12
+0% +$22.4K 0.38% 25
2018
Q1 		$71.1M Buy
35,552
+18,701
+111% +$41M 0.6% 21
2017
Q4 		$38.6M Buy
16,851
+7,368
+78% +$16.8M 0.34% 29
2017
Q3 		$23M Buy
9,483
+11
+0.1% +$23K 0.19% 37
2017
Q2 		$17.7M Buy
9,472
+8
+0.1% +$16.7K 0.15% 34
2017
Q1 		$25.4M Buy
9,464
+13
+0.1% +$25.1K 0.21% 31
2016
Q4 		$15.4M Buy
9,451
+2,998
+46% +$5.72M 0.15% 38
2016
Q3 		$18M Buy
6,453
+12
+0.2% +$25.4K 0.16% 38
2016
Q2 		$10.7M Buy
6,441
+10
+0.2% +$17.6K 0.11% 51
2016
Q1 		$13.8M Buy
6,431
+6
+0.1% +$12.8K 0.15% 45
2015
Q4 		$21.6M Buy
6,425
+7
+0.1% +$25.1K 0.18% 41
2015
Q3 		$23.4M Buy
6,418
+5
+0.1% +$17.7K 0.22% 38
2015
Q2 		$25.9M Buy
6,413
+5
+0.1% +$18.4K 0.23% 41
2015
Q1 		$25.8M Buy
6,408
+4,910
+328% +$24M 0.21% 37
2014
Q4 		$7.18M Buy
1,498
+8
+0.5% +$25.7K 0.07% 60
2014
Q3 		$3.71M Buy
1,490
+6
+0.4% +$17.3K 0.05% 73
2014
Q2 		$4.68M Hold
1,484
– – 0.06% 72
2014
Q1 		$6.58M Sell
1,484
-1,434
-49% -$7.85M 0.08% 64
2013
Q4 		$14.7M Sell
2,918
-2,478
-46% -$6.61M 0.21% 39
2013
Q3 		$10.2M Buy
5,396
+1,256
+30% +$2.01M 0.15% 43
2013
Q2 		$2.95M Buy
+4,140
New +$2.98M 0.06% 57

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Baker Bros. Advisors's ACGN Position: Q2 2021 in Review

Baker Bros. Advisors sold out of Aceragen Inc (ACGN) in Q2 2021, closing a stake of 120,543 shares — an estimated $2.66M sold.

Baker Bros. Advisors first reported a position in ACGN in Q2 2013 and held it in 32 quarters. The position peaked at $71.1M in Q1 2018. 47 funds tracked by Wall St. Rank hold ACGN as of Q2 2021.

  • Baker Bros. Advisors reported no remaining Aceragen Inc position as of Q2 2021 after selling out during the quarter.
  • Baker Bros. Advisors sold 120,543 Aceragen Inc shares in Q2 2021, an estimated $2.66M.
  • Baker Bros. Advisors first reported a position in Aceragen Inc in Q2 2013 and held it in 32 quarters.
  • Baker Bros. Advisors's Aceragen Inc position peaked at $71.1M in Q1 2018.
  • 47 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2021.

Based on Baker Bros. Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.